HN2000000056A - Nuevas formas cristalinas de un antibiotico macrolido - Google Patents

Nuevas formas cristalinas de un antibiotico macrolido

Info

Publication number
HN2000000056A
HN2000000056A HN2000000056A HN2000000056A HN2000000056A HN 2000000056 A HN2000000056 A HN 2000000056A HN 2000000056 A HN2000000056 A HN 2000000056A HN 2000000056 A HN2000000056 A HN 2000000056A HN 2000000056 A HN2000000056 A HN 2000000056A
Authority
HN
Honduras
Prior art keywords
macrolid
antibiotic
crystal forms
new crystal
new
Prior art date
Application number
HN2000000056A
Other languages
English (en)
Spanish (es)
Inventor
Allen Douglas John Meldrum
Morton Barry James
Rafka Robert John
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of HN2000000056A publication Critical patent/HN2000000056A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HN2000000056A 1999-05-18 2000-04-25 Nuevas formas cristalinas de un antibiotico macrolido HN2000000056A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13464499P 1999-05-18 1999-05-18

Publications (1)

Publication Number Publication Date
HN2000000056A true HN2000000056A (es) 2001-02-02

Family

ID=22464300

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2000000056A HN2000000056A (es) 1999-05-18 2000-04-25 Nuevas formas cristalinas de un antibiotico macrolido

Country Status (43)

Country Link
US (1) US6583274B1 (enExample)
EP (1) EP1189912B1 (enExample)
JP (1) JP3897983B2 (enExample)
KR (1) KR100474229B1 (enExample)
CN (1) CN1203084C (enExample)
AP (1) AP2001002325A0 (enExample)
AR (1) AR020030A1 (enExample)
AT (1) ATE392427T1 (enExample)
AU (1) AU772283B2 (enExample)
BG (1) BG106150A (enExample)
BR (1) BR0011300A (enExample)
CA (1) CA2372206C (enExample)
CZ (1) CZ20014120A3 (enExample)
DE (1) DE60038610T2 (enExample)
DK (1) DK1189912T3 (enExample)
DZ (1) DZ3043A1 (enExample)
EA (1) EA003417B1 (enExample)
ES (1) ES2302689T3 (enExample)
GT (1) GT200000072A (enExample)
HK (1) HK1045521B (enExample)
HN (1) HN2000000056A (enExample)
HR (1) HRP20010849A2 (enExample)
HU (1) HUP0201341A3 (enExample)
IL (2) IL145946A0 (enExample)
IS (1) IS6127A (enExample)
MA (1) MA26735A1 (enExample)
MX (1) MXPA01011914A (enExample)
MY (1) MY133397A (enExample)
NO (1) NO320195B1 (enExample)
NZ (1) NZ514765A (enExample)
OA (1) OA11876A (enExample)
PA (1) PA8495001A1 (enExample)
PE (1) PE20010151A1 (enExample)
PL (1) PL353316A1 (enExample)
PT (1) PT1189912E (enExample)
SK (1) SK16472001A3 (enExample)
TN (1) TNSN00103A1 (enExample)
TW (1) TWI225066B (enExample)
UA (1) UA67842C2 (enExample)
UY (1) UY26144A1 (enExample)
WO (1) WO2000069874A1 (enExample)
YU (1) YU76601A (enExample)
ZA (1) ZA200109420B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465437B1 (en) * 1999-06-30 2002-10-15 Pfizer Inc. Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
WO2001055158A1 (en) 2000-01-27 2001-08-02 Pfizer Products Inc. Azalide antibiotic compositions
BR0209241A (pt) * 2001-04-27 2004-06-15 Pfizer Prod Inc Processo para preparação de derivados de9-deoxo-9a-aza-9a-homoeritromicina a 4-substituida
EP1435359A1 (en) * 2002-12-31 2004-07-07 Alembic Limited A process for the purification of roxithromycin
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
MX2011008074A (es) * 2009-01-30 2011-08-17 Glaxo Group Ltd Macrolido anti-inflamatorio.
EP2402355A1 (en) * 2010-07-01 2012-01-04 Novartis AG Crystalline anhydrous forms II and III of Tulathromycin
EP2736915A1 (en) 2011-07-27 2014-06-04 Farma GRS, d.o.o. New crystalline forms of tulathromycin
CN106008622A (zh) * 2016-08-02 2016-10-12 海门慧聚药业有限公司 泰拉霉素新晶型及其制备
CN109942652B (zh) * 2017-12-21 2022-04-26 洛阳惠中兽药有限公司 一种莱柯霉素晶型ⅰ及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX12213A (es) * 1987-07-09 1993-05-01 Pfizer Metodo de preparacion de dihidrato de azitromicina cristalino
US5441939A (en) * 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
US5844105A (en) * 1996-07-29 1998-12-01 Abbott Laboratories Preparation of crystal form II of clarithromycin
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.

Also Published As

Publication number Publication date
CN1203084C (zh) 2005-05-25
OA11876A (en) 2006-03-27
AR020030A1 (es) 2002-03-27
DE60038610D1 (de) 2008-05-29
TWI225066B (en) 2004-12-11
ZA200109420B (en) 2002-11-15
YU76601A (sh) 2004-09-03
GT200000072A (es) 2001-11-08
AU3572900A (en) 2000-12-05
KR20020007415A (ko) 2002-01-26
EA200100984A1 (ru) 2002-06-27
PT1189912E (pt) 2008-05-16
NO20015598L (no) 2002-01-08
PA8495001A1 (es) 2002-02-21
ATE392427T1 (de) 2008-05-15
PL353316A1 (en) 2003-11-17
JP3897983B2 (ja) 2007-03-28
IS6127A (is) 2001-10-26
NZ514765A (en) 2004-05-28
HK1045521A1 (en) 2002-11-29
AU772283B2 (en) 2004-04-22
EA003417B1 (ru) 2003-04-24
NO20015598D0 (no) 2001-11-16
HUP0201341A2 (en) 2002-08-28
MY133397A (en) 2007-11-30
MXPA01011914A (es) 2002-05-06
AP2001002325A0 (en) 2001-12-31
IL145946A (en) 2007-06-17
BG106150A (bg) 2002-05-31
DE60038610T2 (de) 2009-06-25
HUP0201341A3 (en) 2003-03-28
EP1189912B1 (en) 2008-04-16
EP1189912A1 (en) 2002-03-27
TNSN00103A1 (fr) 2005-11-10
KR100474229B1 (ko) 2005-03-08
NO320195B1 (no) 2005-11-14
PE20010151A1 (es) 2001-02-08
HRP20010849A2 (en) 2003-04-30
DZ3043A1 (fr) 2004-03-27
UA67842C2 (uk) 2004-07-15
WO2000069874A1 (en) 2000-11-23
MA26735A1 (fr) 2004-12-20
CA2372206A1 (en) 2000-11-23
BR0011300A (pt) 2002-02-26
CZ20014120A3 (cs) 2003-01-15
UY26144A1 (es) 2000-12-29
SK16472001A3 (sk) 2003-02-04
HK1045521B (zh) 2005-12-09
CA2372206C (en) 2006-01-10
IL145946A0 (en) 2002-07-25
ES2302689T3 (es) 2008-08-01
US6583274B1 (en) 2003-06-24
CN1351607A (zh) 2002-05-29
JP2002544283A (ja) 2002-12-24
DK1189912T3 (da) 2008-06-30

Similar Documents

Publication Publication Date Title
HN2001000146A (es) Derivados de pirazol
HN2002000300A (es) Nuevos derivados de piperazina
GT199900102A (es) Fenoxipropanolaminas, procedimiento para su preparacìon y composiciones farmacèuticasque las contienen.
HN2001000217A (es) Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa - 7
HN2002000319A (es) Benzamida, heteroarilamida y amidas inversas
ECSP066467A (es) Formas Polimórficas de 3-(4-amino-1-Oxo-1-3 DIhidroisoindol-2-IL)-Piperidin-2,6-Diona
HN2001000027A (es) Derivados de purina
HN2003000054A (es) Formas de dosificacion farmaceutica de liberacion controlada de un inhibidor de la proteina de transferencia de ester de colesterilo (cetpi), a procedimientos de uso y a procedimientos de preparacion de las mismas.
HN2006019066A (es) "(s)-n-metilnaltrexona"
BR0317715A (pt) Composições e processos de uso de collajolie
PA8506301A1 (es) Cristal de 4- carboxamino- 1,2,3,4,- tetrahidroquinolina 2-sustituida
HN2001000281A (es) Nuevas imidazotriazinonas sustituidas
CR8357A (es) Derivados de tetrahidronaftaleno, procedimiento para su preparacion y su uso como antiinflamatorio
CO5180587A1 (es) Composicion farmaceutica de orlistat que contiene tensoactivos y dispersantes
PA8577201A1 (es) 3-fenil-propionamido, 3-fenil-acrilamido y derivados 3-fenil-propinamido como inhibidores de mao-b
HN2001000235A (es) Derivados puentes de piperazina
ECSP034531A (es) Derivados sustituidos de c-ciclohexilmetilamina
HN2000000056A (es) Nuevas formas cristalinas de un antibiotico macrolido
HN2001000278A (es) Procedimiento para la preparacion de imidazotriazininas substituidas con sulfonamida.
SV2003000741A (es) Compuesto lactamico x-13170
CO4600682A1 (es) Protrombinas como antidoto para los inhibidores de la trom- bina
HN2002000278A (es) Tetrahidroquinolinas
AR030662A1 (es) Beta-tio-alfa-aminoacidos, procedimiento para su fabricacion, medicamentos que contienen estos compuestos y el uso de los tioaminoacidos para la preparacion de medicamentos
ES2186989T3 (es) Cristales de maltitol de formas especificas, compuestos cristalinos que los contienen y procedimientos para su preparacion.
ES2174297T3 (es) Nuevos derivados de piranosidos.